[an error occurred while processing this directive] | [an error occurred while processing this directive]
Association between the timing of brain metastases and the prognosis of small cell lung cancer
Sun Han, Wang Youyou, Xu Kunpeng, Xu Liming, Qi Jing, Zhao Lujun
Department of Radiation Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin Clinical Research Center for Cancer,Tianjin 300060,China
AbstractObjective To investigate the association between the timing of brain metastases and the prognosis of patients with small cell lung cancer (SCLC). Methids A retrospective analysis was performed in 131 patients with limited-stage SCLC firstly metastasized to the brain were admitted to our hospital from 2007 to 2015.According to the median bone metastasis-free survival (BMFS),all patients were divided into A group (BMFS≤10 months,n=61) and B group (BMFS>10 months,n=70).The survival rates were analyzed using the Kaplan-Meier method. Between-group comparison was performed by log-rank test. The Cox regression model was used for multivariate prognostic analysis. Results In all 131 patients,the median overall survival (OS) and 1-,2-,and 3-year OS rates were 22.5 months,87.3%,44.7%,and 20.8%,respectively. The median OS after brain metastases and 1-and 2-year OS rates were 9.3 months,39.3% and 14.8%,respectively. No statistical significance was observed in the median OS after brain metastases between the A and B groups (8.6 vs. 9.3 months,P=0.695).Moreover,the OS after brain metastases did not significantly differ in patients without PCI or those receiving different therapies after brain metastases between two groups (P=0.240-0.731). Conclusions The timing of SCLC with brain metastases is significantly correlated with the OS rather than the OS after brain metastases. Therefore,prevention of brain metastases may be an effective approach to prolong the OS of patients with SCLC.
Sun Han,Wang Youyou,Xu Kunpeng et al. Association between the timing of brain metastases and the prognosis of small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2019, 28(5): 339-343.
Sun Han,Wang Youyou,Xu Kunpeng et al. Association between the timing of brain metastases and the prognosis of small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2019, 28(5): 339-343.
[1] Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108. [2] Seute T,Leffers P,ten Velde GP,et al. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma[J].Cancer,2004,100(4):801-06.DOI:10.1002/cncr.20043. [3] Postmus PE,Haaxma-Reiche H,Gregor A,et al. Brain-only metastases of small cell lung cancer;efficacy of whole brain radiotherapy. An EORTC phase Ⅱ study[J].Radiother Oncol,1998,46(1):29-32. [4] Li B,Wang C,Zhang Y,et al. Elevated PLGF contributes to small-cell lung cancer brain metastasis[J].Oncogene,2013,32(24):2952-962.DOI:10.1038/onc.2012.313 [5] Li XX,Li RJ,Zhao LJ,et al. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance[J].Int J Clin Exp Pathol,2015,8(11):14676-14684. [6] Nugent JL,Bunn PA,Jr. Matthews MJ,et al. CNS metastases in small cell bronchogenic carcinoma:increasing frequency and changing pattern with lengthening survival[J].Cancer,1979,44(5):1885-1893. [7] 刘志艳,刘宁波,张宝忠,等.局限期小细胞肺癌放化疗后疗效与脑转移的关系探讨[J].中国肿瘤临床,2015,42(15):756-759.DOI:10.3969/j.issn.1000-8179.20150449. Liu ZY,Liu NB,Zhang BZ,et al. Relationship between the curative effect of chemoradiotherapy and brain metastasis in limited-disease small cell lung cancer[J]. Chinese Journal of Clinical Oncology,2015,42(15):756-759.DOI:10.3969/j.issn.1000-8179.20150449. [8] Wu AJ,Gillis A,Foster A,et al. Patterns of failure in limited-stage small cell lung cancer:Implications of TNM stage for prophylactic cranial irradiation[J].Radiother Oncol,2017,125(1):130-135.DOI:10.1016/j.radonc.2017.07.019. [9] Zabel A,Milker-Zabel S,Thilmann C,et al. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery:prognostic factors[J].Lung Cancer,2002,37(1):87-94. [10] Flannery TW,Suntharalingam M,Kwok Y,et al. Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer[J].Lung Cancer,2003,42(3):327-333. [11] Abrahams JM,Torchia M,Putt M,et al. Risk factors affecting survival after brain metastases from non-small cell lung carcinoma:a follow-up study of 70 patients[J].J Neurosurg,2001,95(4):595-600.doi:10.3171/jns.2001.95.4.0595. [12] 李祥攀,肖建平,陈秀军,等.小细胞肺癌脑转移全脑放疗失败后挽救性分次立体定向放疗疗效分析[J].中华放射肿瘤学杂志,2012,1(21):20-22.DOI:10.3760/cma.j.issn.1004-4221.2012.01.007. Li XP,Xiao JP,Chen XJ,et al. Fractionated stereotactic radiotherapy for recurrent small cell lung cancer brain metastases after whole brain radiotherapy[J].Chin J Radiat Oncol,2012,1(21):20-22.DOI:10.3760/cma.j.issn.1004-4221.2012.01.007. [13] Bernhardt D,Adeberg S,Bozorgmehr F,et al. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy[J].J Neurooncol,2017,134(1):205-212.DOI:10.1007/s11060-017-2510-0. [14] 罗婧,徐利明,赵路军,等.322例广泛期SCLC不同转移部位的生存分析[J].中华放射肿瘤学杂志,2017,1(26):17-21.DOI:10.3760/cma.j.issn.1004-4221.2017.01.004. Luo J,Xu LM,Zhao LJ,et al. The survival analysis of different metastasis sites for 332 patients of extensive stage small cell lung cancer[J].Chin J Radiat Oncol,2017,1(26):17-21.DOI:10.3760/cma.j.issn.1004-4221.2017.01.004. [15] Postmus PE.Brain metastases from small cell lung cancer:chemotherapy,radiotherapy,or both?[J].Semin Radiat Oncol, 1995,5(1):69-73.DOI:10.1054/SRAO00500069. [16] Lawson MH,Cummings NM,Rassl DM,et al. Two novel determinants of etoposide resistance in small cell lung cancer[J].Cancer Res,2011,71(14):4877-4887.DOI:10.1158/0008-5472.CAN-11-0080. [17] Ramlov A,Tietze A,Khalil AA,et al. Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence,survival and morbidity[J].Lung Cancer,2012,77(3):561-566.DOI:10.1016/j.lungcan.2012.05.101. [18] Sperduto PW,Chao ST,Sneed PK,et al. Diagnosis-specific prognostic factors,indexes,and treatment outcomes for patients with newly diagnosed brain metastases:a multi-institutional analysis of 4,259 patients[J].Int J Radiat Oncol Biol Phys,2010,77(3):655-661.DOI:10.1016/j.ijrobp.2009.08.025. [19] Rades D,Dziggel L,Segedin B,et al. The first survival score for patients with brain metastases from small cell lung cancer (SCLC)[J].Clin Neurol Neurosurg,2013,115(10):2029-2032.DOI:10.1016/j.clineuro.2013.06.019.
2019, Vol. 28 
